LUMEN BIOSCIENCE

Serial Number 90767283
Registration 7811710
700

Registration Progress

Application Filed
Jun 10, 2021
Under Examination
Dec 27, 2022
Approved for Publication
Nov 1, 2022
Published for Opposition
Nov 1, 2022
Registered
May 27, 2025

Basic Information

Serial Number
90767283
Registration Number
7811710
Filing Date
June 10, 2021
Registration Date
May 27, 2025
Published for Opposition
November 1, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 27, 2025
Registration
Registered
Classes
001 005

Rights Holder

Lumen Bioscience, Inc.

03
Address
PO Box 4610
Bridgeport, WV 26330-4610

Ownership History

Lumen Bioscience, Inc.

Original Applicant
03
Seattle, WA

Lumen Bioscience, Inc.

Owner at Publication
03
Bridgeport, WV

Lumen Bioscience, Inc.

Original Registrant
03
Bridgeport, WV

Legal Representation

Attorney
Emily M. Haas

USPTO Deadlines

Next Deadline
2148 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-05-27)
Due Date
May 27, 2031
Grace Period Ends
November 27, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description
May 27, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 27, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER
May 8, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 8, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 24, 2025 ALIE A ASSIGNED TO LIE
Mar 24, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 4, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 4, 2025 CNRT W SU - NON-FINAL ACTION - WRITTEN
Mar 4, 2025 GNRT O NON-FINAL ACTION E-MAILED
Jan 18, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 18, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Nov 4, 2024 EISU I TEAS STATEMENT OF USE RECEIVED
Nov 4, 2024 IUAF S USE AMENDMENT FILED
Jun 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 4, 2024 EXT3 S SOU EXTENSION 3 FILED
Jun 4, 2024 EX3G S SOU EXTENSION 3 GRANTED
Jun 4, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 1, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 1, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 1, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 1, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 1, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 1, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 23, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 21, 2023 EX2G S SOU EXTENSION 2 GRANTED
Dec 21, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 21, 2023 EXT2 S SOU EXTENSION 2 FILED
Apr 11, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 7, 2023 EX1G S SOU EXTENSION 1 GRANTED
Apr 7, 2023 EXT1 S SOU EXTENSION 1 FILED
Apr 7, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 27, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 1, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 1, 2022 PUBO A PUBLISHED FOR OPPOSITION
Oct 12, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 26, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 26, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED
Sep 26, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED
Sep 26, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN
Sep 26, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 14, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 14, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 14, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 16, 2022 CEPE I COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Mar 16, 2022 ALIE A ASSIGNED TO LIE
Mar 16, 2022 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Mar 16, 2022 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Mar 16, 2022 GEAP F EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

Detailed Classifications

Class 001
Chemical additives derived from microalgae, namely, cyanobacteria, for use in the manufacture of pharmaceuticals, cosmetics, veterinary preparations, and foodstuffs
First Use Anywhere: Aug 29, 2023
First Use in Commerce: Aug 29, 2023
Class 005
Vaccine preparations; adjuvants for use with vaccines; therapeutic antibodies for use as immunotherapeutic agents for targeting toxins, viruses and enterotoxic bacteria; biologic preparations for medical and therapeutic purposes, namely, the treatment and prevention of infectious diseases, deficiency diseases, hereditary diseases, physiological diseases, metabolic diseases, autoimmune diseases and gastrointestinal diseases; therapeutic agents for medical purposes, namely, biologic drugs targeted to treat specific diseases, namely, infectious diseases, deficiency diseases, hereditary diseases, physiological diseases, metabolic diseases, autoimmune diseases and gastrointestinal diseases
First Use Anywhere: Aug 29, 2023
First Use in Commerce: Aug 29, 2023

Classification

International Classes
001 005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCE"